Yatsen Holding Limited (YSG) 10-Year Financial Performance & Capital Metrics

YSG • • Industrial / General

Consumer CyclicalSpecialty RetailSpecialty Health & BeautyPersonal Care Retailers

AboutYatsen Holding Limited, together with its subsidiaries, engages in the development and sale of beauty products under the Perfect Diary, Little Ondine, Pink Bear, Abby's Choice, GalÃnic, DR.WU, Eve Lom, and EANTiM brands in the People's Republic of China. It offers color cosmetics, eye makeup, lip makeup, face makeup, skincare, and nail products; and makeup tools and accessories, including brush sets, cotton cosmetic pads, mirrors, and makeup sponges. The company also provides kits; and other products, such as perfumes and cross-over products comprising beauty devices and colored contact lenses. It sells its products through stores and online channel. The company was formerly known as Mangrove Bay Ecommerce Holding (Cayman) and changed its name to Yatsen Holding Limited in January 2019. Yatsen Holding Limited was founded in 2016 and is headquartered in Guangzhou, China.Show more

Revenue $3.44B +0.8%
EBITDA -$205M +42.5%
Net Income -$718M +3.6%
EPS (Diluted) -7.00 -2.9%
Gross Margin 77.13% +4.8%
EBITDA Margin -5.95% +43.0%
Operating Margin -12.43% +24.1%
Net Margin -20.87% +4.3%
ROE -19.71% -22.4%
ROIC -10.88% +7.3%
Debt/Equity 0.05 +77.4%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Share count reduced 7.8% through buybacks
✓Trading at only 0.1x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 10 (bottom 10%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y2.63%

3Y-15.8%

TTM23.69%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM40.41%

EPS CAGR

10Y-

5Y-

3Y-

TTM35.69%

ROCE

10Y Avg-18.08%

5Y Avg-24.54%

3Y Avg-12.95%

Latest-11.07%

Peer Comparison

Personal Care Retailers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NHTCNatural Health Trends Corp.	43.17M	3.75	75.30	-2.19%	-0.29%	-0.45%		0.08
OLPXOlaplex Holdings, Inc.	1.1B	1.65	56.31	-7.77%	-1.18%	-0.56%	12.89%	0.74
ULTAUlta Beauty, Inc.	29.51B	665.12	26.25	0.79%	10.31%	46.14%	3.27%	0.77
SBHSally Beauty Holdings, Inc.	1.56B	15.89	8.41	-0.42%	5.29%	24.66%	11.06%	1.97
BBWIBath & Body Works, Inc.	4.79B	23.40	6.48	-1.64%	9.5%		13.78%
JWELJowell Global Ltd.	4.67M	2.15	-0.59	-16.89%	-6.63%	-114.89%	14.28%	0.13
YSGYatsen Holding Limited	275.1M	4.30	-0.61	0.8%	-11.76%	-15.88%		0.05
HNSTThe Honest Company, Inc.	289.54M	2.59	-42.39	9.87%	1.85%	3.72%	0.35%	0.12

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	660.1M	3.02B	4.95B	5.76B	3.77B	3.41B	3.44B
Revenue Growth %	-	3.58%	0.64%	0.17%	-0.35%	-0.09%	0.01%
Cost of Goods Sold+	241.13M	1.1B	1.77B	1.92B	1.21B	901.33M	787.24M
COGS % of Revenue	0.37%	0.36%	0.36%	0.33%	0.32%	0.26%	0.23%
Gross Profit+	418.97M	1.92B	3.18B	3.85B	2.56B	2.51B	2.65B
Gross Margin %	0.63%	0.64%	0.64%	0.67%	0.68%	0.74%	0.77%
Gross Profit Growth %	-	3.59%	0.65%	0.21%	-0.33%	-0.02%	0.06%
Operating Expenses+	453.59M	1.78B	5.72B	5.45B	3.51B	3.07B	3.08B
OpEx % of Revenue	0.69%	0.59%	1.16%	0.95%	0.93%	0.9%	0.9%
Selling, General & Admin	450.84M	1.76B	5.65B	5.31B	3.38B	2.96B	2.97B
SG&A % of Revenue	0.68%	0.58%	1.14%	0.92%	0.9%	0.87%	0.86%
Research & Development	2.74M	23.12M	62.88M	140.25M	129.1M	111.68M	110.84M
R&D % of Revenue	0%	0.01%	0.01%	0.02%	0.03%	0.03%	0.03%
Other Operating Expenses	0	0	0	0	0	0	0
Operating Income+	-34.61M	143.37M	-2.54B	-1.6B	-945.21M	-559.24M	-427.79M
Operating Margin %	-0.05%	0.05%	-0.51%	-0.28%	-0.25%	-0.16%	-0.12%
Operating Income Growth %	-	5.14%	-18.69%	0.37%	0.41%	0.41%	0.24%
EBITDA+	-30.34M	210.86M	-2.29B	-1.18B	-599.99M	-355.86M	-204.61M
EBITDA Margin %	-0.05%	0.07%	-0.46%	-0.2%	-0.16%	-0.1%	-0.06%
EBITDA Growth %	-	7.95%	-11.84%	0.48%	0.49%	0.41%	0.43%
D&A (Non-Cash Add-back)	4.28M	67.49M	249.47M	421.73M	345.22M	203.38M	223.18M
EBIT	-37.3M	146.94M	-2.54B	-1.53B	-845.77M	-763.46M	-724.82M
Net Interest Income+	-214K	5.32M	14.31M	45.66M	34.66M	89.02M	86.14M
Interest Income	0	5.32M	14.31M	45.66M	34.66M	89.02M	86.14M
Interest Expense	214K	0	0	0	0	0	0
Other Income/Expense	-2.91M	3.56M	1.16M	75.3M	112.21M	-194.09M	-295.62M
Pretax Income+	-37.52M	146.94M	-2.54B	-1.53B	-833.01M	-753.34M	-723.41M
Pretax Margin %	-0.06%	0.05%	-0.51%	-0.27%	-0.22%	-0.22%	-0.21%
Income Tax+	4.17M	71.78M	6.59M	-909.07K	2.75M	-3.21M	-3.13M
Effective Tax Rate %	1.11%	0.51%	1%	1%	1%	0.99%	0.99%
Net Income+	-41.69M	75.16M	-2.54B	-1.52B	-829.69M	-744.69M	-718.21M
Net Margin %	-0.06%	0.02%	-0.51%	-0.26%	-0.22%	-0.22%	-0.21%
Net Income Growth %	-	2.8%	-34.81%	0.4%	0.45%	0.1%	0.04%
Net Income (Continuing)	-41.69M	75.16M	-2.54B	-1.53B	-835.76M	-750.13M	-720.29M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	15.08M	348.31M	343.08M	49.74M	47.69M
EPS (Diluted)+	-0.05	-0.05	-4.60	-12.20	-7.40	-6.80	-7.00
EPS Growth %	-	0.09%	-94.83%	-1.65%	0.39%	0.08%	-0.03%
EPS (Basic)	-0.05	-0.05	-4.60	-12.20	-7.40	-6.80	-7.00
Diluted Shares Outstanding	134.86M	134.86M	126.32M	126.34M	112.34M	109.79M	101.25M
Basic Shares Outstanding	134.86M	134.86M	126.32M	126.29M	111.13M	109.79M	101.17M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	287.96M	1.57B	7.09B	4.56B	3.51B	2.95B	2.35B
Cash & Short-Term Investments	25.06M	686.58M	5.73B	3.2B	2.59B	2.06B	1.36B
Cash Only	25.06M	676.58M	5.73B	3.14B	1.51B	836.89M	817.39M
Short-Term Investments	0	10M	0	62.88M	1.07B	1.22B	539.13M
Accounts Receivable	64.75M	265.3M	419.32M	355.9M	206.44M	201.64M	326.89M
Days Sales Outstanding	35.8	32.03	30.93	22.54	19.98	21.56	34.67
Inventory	87.49M	504.05M	616.81M	695.76M	423.29M	352.09M	386.05M
Days Inventory Outstanding	132.44	167.17	127.4	132.54	127.87	142.58	178.99
Other Current Assets	95.44M	80.84M	150.04M	103.65M	121.67M	231.79M	60.47M
Total Non-Current Assets+	40.26M	438.49M	1.22B	2.72B	2.35B	2.05B	1.62B
Property, Plant & Equipment	23.43M	372.76M	822.01M	668.28M	208.62M	179.23M	221.87M
Fixed Asset Turnover	28.18x	8.11x	6.02x	8.63x	18.08x	19.05x	15.51x
Goodwill	0	20.6M	20.6M	869.42M	857.14M	556.57M	155.03M
Intangible Assets	1.11M	10.03M	189.09M	745.85M	689.67M	671.4M	559.71M
Long-Term Investments	3M	29.68M	34.86M	350.38M	502.58M	618.75M	664.58M
Other Non-Current Assets	12.08M	1.2M	152.06M	80.22M	94.27M	28.48M	20.64M
Total Assets+	328.22M	2.01B	8.31B	7.27B	5.86B	5.01B	3.97B
Asset Turnover	2.01x	1.50x	0.60x	0.79x	0.64x	0.68x	0.87x
Asset Growth %	-	5.12%	3.13%	-0.12%	-0.19%	-0.15%	-0.21%
Total Current Liabilities+	187.26M	763.34M	1.13B	877.58M	588.41M	611.33M	640.19M
Accounts Payable	90.22M	400.54M	466.7M	240.81M	119.85M	105.69M	72.09M
Days Payables Outstanding	136.57	132.84	96.4	45.87	36.21	42.8	33.42
Short-Term Debt	2.9M	0	0	0	0	0	0
Deferred Revenue (Current)	1K	1000K	1000K	1000K	1000K	0	0
Other Current Liabilities	10.34M	97.78M	60.51M	70.15M	55.87M	120.12M	39.66M
Current Ratio	1.54x	2.06x	6.27x	5.19x	5.96x	4.83x	3.67x
Quick Ratio	1.07x	1.40x	5.72x	4.40x	5.24x	4.25x	3.06x
Cash Conversion Cycle	31.67	66.36	61.94	109.2	111.65	121.34	180.24
Total Non-Current Liabilities+	11.54M	172.79M	313.47M	386.93M	211.72M	209.91M	227.66M
Long-Term Debt	0	0	0	0	0	0	0
Capital Lease Obligations	11.54M	171.04M	311.91M	206.3M	53M	67.77M	109.53M
Deferred Tax Liabilities	0	1.74M	1.56M	124.45M	113.44M	111.59M	103.31M
Other Non-Current Liabilities	0	0	1.56M	0	0	0	0
Total Liabilities	198.81M	936.13M	1.44B	1.26B	800.13M	821.24M	867.85M
Total Debt+	22.77M	264.96M	527.21M	421.15M	132.58M	113.23M	148.94M
Net Debt	-2.29M	-411.62M	-5.2B	-2.72B	-1.38B	-723.66M	-668.46M
Debt / Equity	0.18x	0.25x	0.08x	0.07x	0.03x	0.03x	0.05x
Debt / EBITDA	-	1.26x	-	-	-	-	-
Net Debt / EBITDA	-	-1.95x	-	-	-	-	-
Interest Coverage	-161.75x	-	-	-	-	-	-
Total Equity+	129.41M	1.07B	6.86B	6.01B	5.06B	4.18B	3.1B
Equity Growth %	-	7.3%	5.39%	-0.12%	-0.16%	-0.17%	-0.26%
Book Value per Share	0.96	7.97	54.33	47.55	45.07	38.12	30.65
Total Shareholders' Equity	129.41M	1.07B	6.85B	5.66B	4.72B	4.14B	3.06B
Common Stock	47K	56K	173K	173K	173K	173K	173K
Retained Earnings	-59.98M	-89.59M	-4.24B	-5.78B	-6.6B	-7.35B	-8.03B
Treasury Stock	-23K	-20K	-12K	-22.33M	-669.15M	-864.57M	-1.28B
Accumulated OCI	610K	33.75M	-77.21M	-234.43M	-50.02M	84.38M	86.87M
Minority Interest	0	0	15.08M	348.31M	343.08M	49.74M	47.69M

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-96.21M	-6.18M	-983.37M	-1.02B	136.21M	-107.44M	-243.67M
Operating CF Margin %	-0.15%	-0%	-0.2%	-0.18%	0.04%	-0.03%	-0.07%
Operating CF Growth %	-	0.94%	-158.15%	-0.04%	1.13%	-1.79%	-1.27%
Net Income	-40.12M	75.36M	-2.69B	-1.55B	-821.33M	-750.23M	-710.22M
Depreciation & Amortization	4.12M	67.67M	263.87M	427.26M	339.26M	203.41M	0
Stock-Based Compensation	14.03M	75M	1.9B	530.44M	340.86M	77.5M	91.17M
Deferred Taxes	2.29M	-3.69M	3.45M	-5.43M	-8.36M	-8.65M	0
Other Non-Cash Items	4.68M	1.76M	39.53M	104.74M	55.73M	309.02M	574M
Working Capital Changes	-81.21M	-222.27M	-502.39M	-530.41M	230.05M	61.52M	-198.62M
Change in Receivables	-59.93M	-200.55M	-154.01M	99.75M	155M	-4.47M	-5.24M
Change in Inventory	-77.79M	-411.11M	-134.25M	-109.93M	278M	109.44M	-11.16M
Change in Payables	81.2M	310.32M	66.16M	-244.44M	-120.97M	-14.16M	-33.6M
Cash from Investing+	-7.88M	-148.17M	-508.83M	-1.48B	-1.16B	-260.49M	592.12M
Capital Expenditures	-4.88M	-108.76M	-384.58M	-166.74M	-59.33M	-43.65M	-52.74M
CapEx % of Revenue	0.01%	0.04%	0.08%	0.03%	0.02%	0.01%	0.02%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	-4.05M	0	-158.54M	0	4.1M	1.63M	-2.18M
Cash from Financing+	123.68M	795.23M	6.68B	-1.71M	-654.45M	-342.45M	-394.23M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	120.78M	842.49M	7.17B	13.55M	200K	-129.76M	11.57M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	-101.08M	-114.94M	-1.37B	-1.19B	76.88M	-151.41M	-300.69M
FCF Margin %	-0.15%	-0.04%	-0.28%	-0.21%	0.02%	-0.04%	-0.09%
FCF Growth %	-	-0.14%	-10.9%	0.13%	1.06%	-2.97%	-0.99%
FCF per Share	-0.75	-0.85	-10.83	-9.40	0.68	-1.38	-2.97
FCF Conversion (FCF/Net Income)	2.31x	-0.08x	0.39x	0.67x	-0.16x	0.14x	0.34x
Interest Paid	0	0	93K	0	0	0	0
Taxes Paid	0	0	59.44M	6.19M	6.11M	7.75M	2.91M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-32.21%	12.49%	-64.03%	-23.63%	-14.99%	-16.11%	-19.71%
Return on Invested Capital (ROIC)	-20.42%	27.23%	-163.53%	-48.54%	-20.33%	-11.74%	-10.88%
Gross Margin	63.47%	63.59%	64.28%	66.76%	67.96%	73.6%	77.13%
Net Margin	-6.32%	2.49%	-51.36%	-26.38%	-22%	-21.81%	-20.87%
Debt / Equity	0.18x	0.25x	0.08x	0.07x	0.03x	0.03x	0.05x
Interest Coverage	-161.75x	-	-	-	-	-	-
FCF Conversion	2.31x	-0.08x	0.39x	0.67x	-0.16x	0.14x	0.34x
Revenue Growth	-	357.96%	63.66%	16.51%	-34.58%	-9.46%	0.8%

Revenue by Segment

	2022	2023	2024
Other Operating	-	-	31.8M
Other Operating Growth	-	-	-
Others	49.09M	57.47M	-
Others Growth	-	17.06%	-

Frequently Asked Questions

Growth & Financials

Yatsen Holding Limited (YSG) reported $4.07B in revenue for fiscal year 2024. This represents a 516% increase from $660.1M in 2018.

Yatsen Holding Limited (YSG) grew revenue by 0.8% over the past year. Growth has been modest.

Yatsen Holding Limited (YSG) reported a net loss of $478.5M for fiscal year 2024.

Dividend & Returns

Yatsen Holding Limited (YSG) has a return on equity (ROE) of -19.7%. Negative ROE indicates the company is unprofitable.

Yatsen Holding Limited (YSG) had negative free cash flow of $300.7M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Yatsen Holding Limited (YSG) 10-Year Financial Performance & Capital Metrics

YSG • • Industrial / General

Consumer CyclicalSpecialty RetailSpecialty Health & BeautyPersonal Care Retailers

Revenue $3.44B +0.8%
EBITDA -$205M +42.5%
Net Income -$718M +3.6%
EPS (Diluted) -7.00 -2.9%
Gross Margin 77.13% +4.8%
EBITDA Margin -5.95% +43.0%
Operating Margin -12.43% +24.1%
Net Margin -20.87% +4.3%
ROE -19.71% -22.4%
ROIC -10.88% +7.3%
Debt/Equity 0.05 +77.4%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Share count reduced 7.8% through buybacks
✓Trading at only 0.1x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 10 (bottom 10%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y2.63%

3Y-15.8%

TTM23.69%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM40.41%

EPS CAGR

10Y-

5Y-

3Y-

TTM35.69%

ROCE

10Y Avg-18.08%

5Y Avg-24.54%

3Y Avg-12.95%

Latest-11.07%

Peer Comparison

Personal Care Retailers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NHTCNatural Health Trends Corp.	43.17M	3.75	75.30	-2.19%	-0.29%	-0.45%		0.08
OLPXOlaplex Holdings, Inc.	1.1B	1.65	56.31	-7.77%	-1.18%	-0.56%	12.89%	0.74
ULTAUlta Beauty, Inc.	29.51B	665.12	26.25	0.79%	10.31%	46.14%	3.27%	0.77
SBHSally Beauty Holdings, Inc.	1.56B	15.89	8.41	-0.42%	5.29%	24.66%	11.06%	1.97
BBWIBath & Body Works, Inc.	4.79B	23.40	6.48	-1.64%	9.5%		13.78%
JWELJowell Global Ltd.	4.67M	2.15	-0.59	-16.89%	-6.63%	-114.89%	14.28%	0.13
YSGYatsen Holding Limited	275.1M	4.30	-0.61	0.8%	-11.76%	-15.88%		0.05
HNSTThe Honest Company, Inc.	289.54M	2.59	-42.39	9.87%	1.85%	3.72%	0.35%	0.12

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	660.1M	3.02B	4.95B	5.76B	3.77B	3.41B	3.44B
Revenue Growth %	-	3.58%	0.64%	0.17%	-0.35%	-0.09%	0.01%
Cost of Goods Sold+	241.13M	1.1B	1.77B	1.92B	1.21B	901.33M	787.24M
COGS % of Revenue	0.37%	0.36%	0.36%	0.33%	0.32%	0.26%	0.23%
Gross Profit+	418.97M	1.92B	3.18B	3.85B	2.56B	2.51B	2.65B
Gross Margin %	0.63%	0.64%	0.64%	0.67%	0.68%	0.74%	0.77%
Gross Profit Growth %	-	3.59%	0.65%	0.21%	-0.33%	-0.02%	0.06%
Operating Expenses+	453.59M	1.78B	5.72B	5.45B	3.51B	3.07B	3.08B
OpEx % of Revenue	0.69%	0.59%	1.16%	0.95%	0.93%	0.9%	0.9%
Selling, General & Admin	450.84M	1.76B	5.65B	5.31B	3.38B	2.96B	2.97B
SG&A % of Revenue	0.68%	0.58%	1.14%	0.92%	0.9%	0.87%	0.86%
Research & Development	2.74M	23.12M	62.88M	140.25M	129.1M	111.68M	110.84M
R&D % of Revenue	0%	0.01%	0.01%	0.02%	0.03%	0.03%	0.03%
Other Operating Expenses	0	0	0	0	0	0	0
Operating Income+	-34.61M	143.37M	-2.54B	-1.6B	-945.21M	-559.24M	-427.79M
Operating Margin %	-0.05%	0.05%	-0.51%	-0.28%	-0.25%	-0.16%	-0.12%
Operating Income Growth %	-	5.14%	-18.69%	0.37%	0.41%	0.41%	0.24%
EBITDA+	-30.34M	210.86M	-2.29B	-1.18B	-599.99M	-355.86M	-204.61M
EBITDA Margin %	-0.05%	0.07%	-0.46%	-0.2%	-0.16%	-0.1%	-0.06%
EBITDA Growth %	-	7.95%	-11.84%	0.48%	0.49%	0.41%	0.43%
D&A (Non-Cash Add-back)	4.28M	67.49M	249.47M	421.73M	345.22M	203.38M	223.18M
EBIT	-37.3M	146.94M	-2.54B	-1.53B	-845.77M	-763.46M	-724.82M
Net Interest Income+	-214K	5.32M	14.31M	45.66M	34.66M	89.02M	86.14M
Interest Income	0	5.32M	14.31M	45.66M	34.66M	89.02M	86.14M
Interest Expense	214K	0	0	0	0	0	0
Other Income/Expense	-2.91M	3.56M	1.16M	75.3M	112.21M	-194.09M	-295.62M
Pretax Income+	-37.52M	146.94M	-2.54B	-1.53B	-833.01M	-753.34M	-723.41M
Pretax Margin %	-0.06%	0.05%	-0.51%	-0.27%	-0.22%	-0.22%	-0.21%
Income Tax+	4.17M	71.78M	6.59M	-909.07K	2.75M	-3.21M	-3.13M
Effective Tax Rate %	1.11%	0.51%	1%	1%	1%	0.99%	0.99%
Net Income+	-41.69M	75.16M	-2.54B	-1.52B	-829.69M	-744.69M	-718.21M
Net Margin %	-0.06%	0.02%	-0.51%	-0.26%	-0.22%	-0.22%	-0.21%
Net Income Growth %	-	2.8%	-34.81%	0.4%	0.45%	0.1%	0.04%
Net Income (Continuing)	-41.69M	75.16M	-2.54B	-1.53B	-835.76M	-750.13M	-720.29M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	15.08M	348.31M	343.08M	49.74M	47.69M
EPS (Diluted)+	-0.05	-0.05	-4.60	-12.20	-7.40	-6.80	-7.00
EPS Growth %	-	0.09%	-94.83%	-1.65%	0.39%	0.08%	-0.03%
EPS (Basic)	-0.05	-0.05	-4.60	-12.20	-7.40	-6.80	-7.00
Diluted Shares Outstanding	134.86M	134.86M	126.32M	126.34M	112.34M	109.79M	101.25M
Basic Shares Outstanding	134.86M	134.86M	126.32M	126.29M	111.13M	109.79M	101.17M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	287.96M	1.57B	7.09B	4.56B	3.51B	2.95B	2.35B
Cash & Short-Term Investments	25.06M	686.58M	5.73B	3.2B	2.59B	2.06B	1.36B
Cash Only	25.06M	676.58M	5.73B	3.14B	1.51B	836.89M	817.39M
Short-Term Investments	0	10M	0	62.88M	1.07B	1.22B	539.13M
Accounts Receivable	64.75M	265.3M	419.32M	355.9M	206.44M	201.64M	326.89M
Days Sales Outstanding	35.8	32.03	30.93	22.54	19.98	21.56	34.67
Inventory	87.49M	504.05M	616.81M	695.76M	423.29M	352.09M	386.05M
Days Inventory Outstanding	132.44	167.17	127.4	132.54	127.87	142.58	178.99
Other Current Assets	95.44M	80.84M	150.04M	103.65M	121.67M	231.79M	60.47M
Total Non-Current Assets+	40.26M	438.49M	1.22B	2.72B	2.35B	2.05B	1.62B
Property, Plant & Equipment	23.43M	372.76M	822.01M	668.28M	208.62M	179.23M	221.87M
Fixed Asset Turnover	28.18x	8.11x	6.02x	8.63x	18.08x	19.05x	15.51x
Goodwill	0	20.6M	20.6M	869.42M	857.14M	556.57M	155.03M
Intangible Assets	1.11M	10.03M	189.09M	745.85M	689.67M	671.4M	559.71M
Long-Term Investments	3M	29.68M	34.86M	350.38M	502.58M	618.75M	664.58M
Other Non-Current Assets	12.08M	1.2M	152.06M	80.22M	94.27M	28.48M	20.64M
Total Assets+	328.22M	2.01B	8.31B	7.27B	5.86B	5.01B	3.97B
Asset Turnover	2.01x	1.50x	0.60x	0.79x	0.64x	0.68x	0.87x
Asset Growth %	-	5.12%	3.13%	-0.12%	-0.19%	-0.15%	-0.21%
Total Current Liabilities+	187.26M	763.34M	1.13B	877.58M	588.41M	611.33M	640.19M
Accounts Payable	90.22M	400.54M	466.7M	240.81M	119.85M	105.69M	72.09M
Days Payables Outstanding	136.57	132.84	96.4	45.87	36.21	42.8	33.42
Short-Term Debt	2.9M	0	0	0	0	0	0
Deferred Revenue (Current)	1K	1000K	1000K	1000K	1000K	0	0
Other Current Liabilities	10.34M	97.78M	60.51M	70.15M	55.87M	120.12M	39.66M
Current Ratio	1.54x	2.06x	6.27x	5.19x	5.96x	4.83x	3.67x
Quick Ratio	1.07x	1.40x	5.72x	4.40x	5.24x	4.25x	3.06x
Cash Conversion Cycle	31.67	66.36	61.94	109.2	111.65	121.34	180.24
Total Non-Current Liabilities+	11.54M	172.79M	313.47M	386.93M	211.72M	209.91M	227.66M
Long-Term Debt	0	0	0	0	0	0	0
Capital Lease Obligations	11.54M	171.04M	311.91M	206.3M	53M	67.77M	109.53M
Deferred Tax Liabilities	0	1.74M	1.56M	124.45M	113.44M	111.59M	103.31M
Other Non-Current Liabilities	0	0	1.56M	0	0	0	0
Total Liabilities	198.81M	936.13M	1.44B	1.26B	800.13M	821.24M	867.85M
Total Debt+	22.77M	264.96M	527.21M	421.15M	132.58M	113.23M	148.94M
Net Debt	-2.29M	-411.62M	-5.2B	-2.72B	-1.38B	-723.66M	-668.46M
Debt / Equity	0.18x	0.25x	0.08x	0.07x	0.03x	0.03x	0.05x
Debt / EBITDA	-	1.26x	-	-	-	-	-
Net Debt / EBITDA	-	-1.95x	-	-	-	-	-
Interest Coverage	-161.75x	-	-	-	-	-	-
Total Equity+	129.41M	1.07B	6.86B	6.01B	5.06B	4.18B	3.1B
Equity Growth %	-	7.3%	5.39%	-0.12%	-0.16%	-0.17%	-0.26%
Book Value per Share	0.96	7.97	54.33	47.55	45.07	38.12	30.65
Total Shareholders' Equity	129.41M	1.07B	6.85B	5.66B	4.72B	4.14B	3.06B
Common Stock	47K	56K	173K	173K	173K	173K	173K
Retained Earnings	-59.98M	-89.59M	-4.24B	-5.78B	-6.6B	-7.35B	-8.03B
Treasury Stock	-23K	-20K	-12K	-22.33M	-669.15M	-864.57M	-1.28B
Accumulated OCI	610K	33.75M	-77.21M	-234.43M	-50.02M	84.38M	86.87M
Minority Interest	0	0	15.08M	348.31M	343.08M	49.74M	47.69M

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-96.21M	-6.18M	-983.37M	-1.02B	136.21M	-107.44M	-243.67M
Operating CF Margin %	-0.15%	-0%	-0.2%	-0.18%	0.04%	-0.03%	-0.07%
Operating CF Growth %	-	0.94%	-158.15%	-0.04%	1.13%	-1.79%	-1.27%
Net Income	-40.12M	75.36M	-2.69B	-1.55B	-821.33M	-750.23M	-710.22M
Depreciation & Amortization	4.12M	67.67M	263.87M	427.26M	339.26M	203.41M	0
Stock-Based Compensation	14.03M	75M	1.9B	530.44M	340.86M	77.5M	91.17M
Deferred Taxes	2.29M	-3.69M	3.45M	-5.43M	-8.36M	-8.65M	0
Other Non-Cash Items	4.68M	1.76M	39.53M	104.74M	55.73M	309.02M	574M
Working Capital Changes	-81.21M	-222.27M	-502.39M	-530.41M	230.05M	61.52M	-198.62M
Change in Receivables	-59.93M	-200.55M	-154.01M	99.75M	155M	-4.47M	-5.24M
Change in Inventory	-77.79M	-411.11M	-134.25M	-109.93M	278M	109.44M	-11.16M
Change in Payables	81.2M	310.32M	66.16M	-244.44M	-120.97M	-14.16M	-33.6M
Cash from Investing+	-7.88M	-148.17M	-508.83M	-1.48B	-1.16B	-260.49M	592.12M
Capital Expenditures	-4.88M	-108.76M	-384.58M	-166.74M	-59.33M	-43.65M	-52.74M
CapEx % of Revenue	0.01%	0.04%	0.08%	0.03%	0.02%	0.01%	0.02%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	-4.05M	0	-158.54M	0	4.1M	1.63M	-2.18M
Cash from Financing+	123.68M	795.23M	6.68B	-1.71M	-654.45M	-342.45M	-394.23M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	120.78M	842.49M	7.17B	13.55M	200K	-129.76M	11.57M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	-101.08M	-114.94M	-1.37B	-1.19B	76.88M	-151.41M	-300.69M
FCF Margin %	-0.15%	-0.04%	-0.28%	-0.21%	0.02%	-0.04%	-0.09%
FCF Growth %	-	-0.14%	-10.9%	0.13%	1.06%	-2.97%	-0.99%
FCF per Share	-0.75	-0.85	-10.83	-9.40	0.68	-1.38	-2.97
FCF Conversion (FCF/Net Income)	2.31x	-0.08x	0.39x	0.67x	-0.16x	0.14x	0.34x
Interest Paid	0	0	93K	0	0	0	0
Taxes Paid	0	0	59.44M	6.19M	6.11M	7.75M	2.91M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-32.21%	12.49%	-64.03%	-23.63%	-14.99%	-16.11%	-19.71%
Return on Invested Capital (ROIC)	-20.42%	27.23%	-163.53%	-48.54%	-20.33%	-11.74%	-10.88%
Gross Margin	63.47%	63.59%	64.28%	66.76%	67.96%	73.6%	77.13%
Net Margin	-6.32%	2.49%	-51.36%	-26.38%	-22%	-21.81%	-20.87%
Debt / Equity	0.18x	0.25x	0.08x	0.07x	0.03x	0.03x	0.05x
Interest Coverage	-161.75x	-	-	-	-	-	-
FCF Conversion	2.31x	-0.08x	0.39x	0.67x	-0.16x	0.14x	0.34x
Revenue Growth	-	357.96%	63.66%	16.51%	-34.58%	-9.46%	0.8%

Revenue by Segment

	2022	2023	2024
Other Operating	-	-	31.8M
Other Operating Growth	-	-	-
Others	49.09M	57.47M	-
Others Growth	-	17.06%	-

Frequently Asked Questions

Growth & Financials

Yatsen Holding Limited (YSG) reported $4.07B in revenue for fiscal year 2024. This represents a 516% increase from $660.1M in 2018.

Yatsen Holding Limited (YSG) grew revenue by 0.8% over the past year. Growth has been modest.

Yatsen Holding Limited (YSG) reported a net loss of $478.5M for fiscal year 2024.

Dividend & Returns

Yatsen Holding Limited (YSG) has a return on equity (ROE) of -19.7%. Negative ROE indicates the company is unprofitable.

Yatsen Holding Limited (YSG) had negative free cash flow of $300.7M in fiscal year 2024, likely due to heavy capital investments.